Compound Summary
Compound Information
ns 2028
Compound Name: | ns 2028 |
Compound CID: | 4551 |
Synonyms: | ns 2028 204326-43-2 NS-2028 8-bromo-4h-1,2,4oxadiazolo3,4-c1,4benzoxazin-1-one NS2028 More... |
Iupac Name: | 8-bromo-4H-[1,2,4]oxadiazolo[3,4-c][1,4]benzoxazin-1-one |
InChI: | InChI=1S/C9H5BrN2O3/c10-5-1-2-7-6(3-5)12-8(4-14-7)11-15-9(12)13/h1-3H,4H2 |
InChIKey: | MUDRLQRJCGJJTB-UHFFFAOYSA-N |
Canonical Smiles: | C1C2=NOC(=O)N2C3=C(O1)C=CC(=C3)Br |
Isomeric Smiles: | C1C2=NOC(=O)N2C3=C(O1)C=CC(=C3)Br |
Molecular Weight: | 269.05 |
Molecular Formula: | C9H5BrN2O3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
ns 2028
Molecular Weight: | 269.05 |
Molecular Formula: | C9H5BrN2O3 |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 15 |
Complexity: | 333 |
Synonyms
ns 2028
| ns 2028 | ns 2028 |
|---|---|
ns 2028 |
204326-43-2 |
NS-2028 |
8-bromo-4h-1,2,4oxadiazolo3,4-c1,4benzoxazin-1-one |
NS2028 |
UNII-KU8K3G4867 |
4H-8-Bromo-1,2,4-oxadiazolo(3,4-d)benz(b)(1,4)oxazin-1-one |
KU8K3G4867 |
4H-8-Bromo-1,2,4-oxadiazolo3,4-dbenzb1,4oxazin-1-one |
1H,4H-1,2,4Oxadiazolo3,4-c1,4benzoxazin-1-one, 8-bromo- |
8-Bromo-1H,4H-1,2,4oxadiazolo3,4-c1,4benzoxazin-1-one |
8-bromobenzob1,2,4oxadiazolo4,3-d1,4oxazin-1(4H)-one |
SR-01000075533 |
8-Bromo-1H,4H-(1,2,4)oxadiazolo(3,4-C)(1,4)benzoxazin-1-one |
1H,4H-(1,2,4)Oxadiazolo(3,4-C)(1,4)benzoxazin-1-one, 8-bromo- |
Lopac-N-211 |
NS 2028, solid |
Lopac0_000922 |
CHEMBL507122 |
GTPL6554 |
ZINC7253 |
BDBM113770 |
DTXSID901017568 |
HMS3262J06 |
HMS3649M06 |
Tox21_500922 |
1H,4H-1,2,4Oxadiazolo3,4-c1,4benzoxazin-1-one,8-bromo- |
MFCD01530052 |
AKOS024458199 |
CCG-205004 |
LP00922 |
SDCCGSBI-0050897.P002 |
NCGC00015722-01 |
NCGC00015722-02 |
NCGC00015722-03 |
NCGC00015722-04 |
NCGC00094233-01 |
NCGC00094233-02 |
NCGC00261607-01 |
HY-12379 |
CS-0011196 |
EU-0100922 |
N-211 |
NS2028 (1) |
EC-000.2278 |
SR-01000075533-1 |
SR-01000075533-5 |
BRD-K03645807-001-01-7 |
Q27088053 |
4-H-Bromo-1,2,4-oxadiazole(3,4-alpha)benz(b)oxazin-1-one |
8-Bromo-1H,4H-benzob1,2,4oxadiazolo4,3-d1,4oxazin-1-one |
12-bromo-4,8-dioxa-2,5-diazatricyclo7.4.0.0?,?trideca-1(13),5,9,11-tetraen-3-one |
28N |
Experimental Data
ns 2028
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 3 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
ns 2028
Statistics Data
ns 2028
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 3 | 1 | 1 |
Statistics Data Visualization
ns 2028
